BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 30108204)

  • 1. Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis.
    Senzolo M; Riva N; Dentali F; Rodriguez-Castro K; Sartori MT; Bang SM; Martinelli I; Schulman S; Alatri A; Beyer-Westendorf J; Di Minno MND; Ageno W;
    Clin Transl Gastroenterol; 2018 Aug; 9(8):176. PubMed ID: 30108204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.
    Ageno W; Riva N; Schulman S; Beyer-Westendorf J; Bang SM; Senzolo M; Grandone E; Pasca S; Di Minno MN; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Oh D; D'Amico E; Becattini C; De Stefano V; Vidili G; Vaccarino A; Nardo B; Di Nisio M; Dentali F
    JAMA Intern Med; 2015 Sep; 175(9):1474-80. PubMed ID: 26168152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary "Real Life" Experience.
    Rupoli S; Fiorentini A; Morsia E; Svegliati-Baroni G; Micucci G; Maroni L; Garvey KB; Fiorentini A; Riva A; Da Lio L; Benedetti A; Offidani M; Olivieri A; Giuseppe T
    Vasc Health Risk Manag; 2021; 17():619-629. PubMed ID: 34594107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to manage splanchnic vein thrombosis in patients with liver disease.
    Riva N; Ageno W
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):281-288. PubMed ID: 38066910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation Therapy for Splanchnic Vein Thrombosis Associated With Acute Pancreatitis: A Systematic Review and Meta-Analysis.
    Yin Y; Wang L; Gao F; Liu L; Qi X
    Clin Appl Thromb Hemost; 2023; 29():10760296231188718. PubMed ID: 37461391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
    Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
    Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splanchnic vein thrombosis and variceal rebleeding in patients with cirrhosis.
    Amitrano L; Guardascione MA; Scaglione M; Menchise A; Martino R; Manguso F; Lanza AG; Lampasi F
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1381-5. PubMed ID: 23114742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.
    De Gottardi A; Trebicka J; Klinger C; Plessier A; Seijo S; Terziroli B; Magenta L; Semela D; Buscarini E; Langlet P; Görtzen J; Puente A; Müllhaupt B; Navascuès C; Nery F; Deltenre P; Turon F; Engelmann C; Arya R; Caca K; Peck-Radosavljevic M; Leebeek FWG; Valla D; Garcia-Pagan JC;
    Liver Int; 2017 May; 37(5):694-699. PubMed ID: 27778440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Pettinari I; Vukotic R; Stefanescu H; Pecorelli A; Morelli M; Grigoras C; Sparchez Z; Andreone P; Piscaglia F;
    Am J Gastroenterol; 2019 Feb; 114(2):258-266. PubMed ID: 30538290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis.
    Valeriani E; Di Nisio M; Riva N; Cohen O; Porreca E; Senzolo M; De Gottardi A; Magaz M; Garcia-Pagan JC; Ageno W
    Thromb Haemost; 2021 Jul; 121(7):867-876. PubMed ID: 33525037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry.
    Riva N; Ageno W; Schulman S; Beyer-Westendorf J; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Dentali F;
    Lancet Haematol; 2016 Jun; 3(6):e267-75. PubMed ID: 27264036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis.
    Baiges A; Procopet B; Silva-Junior G; Llop E; Tellez L; Darnell A; Garcia-Criado Á; Turon F; Nicoara-Farcau O; González-Alayón C; Larrue H; Magaz M; Olivas P; Perez-Campuzano V; Calleja JL; Albillos A; Reverter JC; Bureau C; Bosch J; Hernández-Gea V; Garcia-Pagán JC; ; ;
    J Hepatol; 2023 Jan; 78(1):114-122. PubMed ID: 36058365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis.
    Tufano A; Ageno W; Di Micco P; Niglio A; Rosa V; Ballaz A; Braester A; Rubio CM; Isern V; Imbalzano E; Monreal M;
    Thromb Res; 2018 Apr; 164():69-74. PubMed ID: 29499439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors for thrombus progression in cirrhotic patients with untreated splanchnic vein thrombosis.
    McMurry H; Sabile JMG; Elstrott B; Chobrutskiy B; Mohinani A; Patel S; Gowda S; Martens K; Shatzel J
    Thromb Res; 2022 Aug; 216():1-7. PubMed ID: 35660708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Splanchnic Vein Thrombosis on Survival: 15-Year Institutional Experience With 1561 Cases.
    Wells PS; Theberge I; Bowdridge J; Kelly E; Kielar A; Forgie MA; John S; van Walraven C
    J Am Heart Assoc; 2020 Dec; 9(24):e016600. PubMed ID: 33269616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses.
    Amitrano L; Guardascione MA; Scaglione M; Pezzullo L; Sangiuliano N; Armellino MF; Manguso F; Margaglione M; Ames PR; Iannaccone L; Grandone E; Romano L; Balzano A
    Am J Gastroenterol; 2007 Nov; 102(11):2464-70. PubMed ID: 17958760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis.
    Caiano LM; Riva N; Ageno W
    Expert Rev Hematol; 2023 Feb; 16(2):121-129. PubMed ID: 36820873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
    Guerrero A; Campo LD; Piscaglia F; Scheiner B; Han G; Violi F; Ferreira CN; Téllez L; Reiberger T; Basili S; Zamora J; Albillos A;
    J Hepatol; 2023 Jul; 79(1):69-78. PubMed ID: 36858157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.